Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Viveve Medical stock

VIVE
US92852W5013
A2QJQB

Price

0.00
Today +/-
+0
Today %
+0 %
P

Viveve Medical stock price

%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Viveve Medical stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Viveve Medical stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Viveve Medical stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Viveve Medical's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Viveve Medical Stock Price History

DateViveve Medical Price
10/2/20240.00 undefined
10/1/20240.00 undefined
9/30/20240.00 undefined
9/27/20240.00 undefined
9/26/20240.00 undefined
9/25/20240.00 undefined
9/24/20240.00 undefined
9/23/20240.00 undefined
9/17/20240.00 undefined
9/16/20240.00 undefined
9/13/20240.00 undefined
9/12/20240.00 undefined
9/10/20240.00 undefined
9/9/20240.00 undefined

Viveve Medical Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Viveve Medical, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Viveve Medical from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Viveve Medical’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Viveve Medical. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Viveve Medical’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Viveve Medical’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Viveve Medical’s growth potential.

Viveve Medical Revenue, EBIT and net profit per share

DateViveve Medical RevenueViveve Medical EBITViveve Medical Net Income
2026e45.22 M undefined-20.89 M undefined-19.89 M undefined
2025e34.88 M undefined-18.01 M undefined-14.38 M undefined
2024e22.33 M undefined-14.32 M undefined-10.61 M undefined
2023e11.36 M undefined-20.53 M undefined-17.5 M undefined
2022e7.03 M undefined-20.93 M undefined-27.88 M undefined
20216.43 M undefined-21.55 M undefined-26.72 M undefined
20205.48 M undefined-18.5 M undefined-26.06 M undefined
20196.57 M undefined-29.93 M undefined-42.91 M undefined
201818.52 M undefined-44.97 M undefined-49.98 M undefined
201715.29 M undefined-33.73 M undefined-36.96 M undefined
20167.14 M undefined-18.7 M undefined-20.11 M undefined
20151.45 M undefined-11.99 M undefined-12.43 M undefined
201490,000 undefined-5.66 M undefined-6.18 M undefined
2013150,000 undefined-3.93 M undefined-4.32 M undefined
20121.08 M undefined-4.13 M undefined-8.39 M undefined
2011670,000 undefined-3.41 M undefined-5.76 M undefined
2010590,000 undefined-3.21 M undefined-510,000 undefined
20094.71 M undefined-1.63 M undefined-1.63 M undefined
20085.33 M undefined-2.11 M undefined-1.94 M undefined
20076 M undefined-2.81 M undefined-2.37 M undefined
20067.15 M undefined-520,000 undefined1.32 M undefined
20057.64 M undefined-1.52 M undefined-1.27 M undefined
20047.57 M undefined-960,000 undefined-830,000 undefined
20038.33 M undefined710,000 undefined520,000 undefined
20028.84 M undefined230,000 undefined310,000 undefined

Viveve Medical Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (M)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M)EBIT (k)EBIT MARGIN (%)NET INCOME (M)NET INCOME GROWTH (%)SHARES (M)DOCUMENTS
199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022e2023e2024e2025e2026e
00235131185111098877765400100171518656711223445
---50.0066.67160.00-15.38-27.27-37.50120.00-9.09-10.00-11.11--12.50---14.29-16.67-20.00------600.00114.2920.00-66.67-16.6720.0016.6757.14100.0054.5532.35
----40.0061.5463.6437.50-45.4530.0044.4450.0050.0057.1457.1457.1450.0060.0050.00------28.5746.6738.8916.67-------
0-100287305344444433200000027710000000
0-1,000-3,000-4,000-2,0001,000-2,000-14,000-17,000-6,000-7,000-4,000000-1,0000-2,000-2,000-1,000-3,000-3,000-4,000-3,000-5,000-11,000-18,000-33,000-44,000-29,000-18,000-21,000-20,000-20,000-14,000-18,000-20,000
---150.00-133.33-40.007.69-18.18-175.00-340.00-54.55-70.00-44.44----14.29--33.33-40.00-25.00---400.00---1,100.00-257.14-220.00-244.44-483.33-360.00-350.00-285.71-181.82-63.64-52.94-44.44
0-2-28-3-22-1-14-16-6-7-3000-11-2-1-10-5-8-4-6-12-20-36-49-42-26-26-27-17-10-14-19
--1,300.00-89.29-33.33-200.00-150.001,300.0014.29-62.5016.67-57.14-----200.00-300.00-50.00---60.00-50.0050.00100.0066.6780.0036.11-14.29-38.10-3.85-37.04-41.1840.0035.71
00000000000000000000000000.010.010.020.030.121.5710.0900000
-------------------------------------
Details

Keystats

ⓘ

Revenue and Growth

The Viveve Medical Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Viveve Medical is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M)RECEIVABLES (M)OTHER REC. (M)INVENTORIES (M)OTHER CURRENT LIAB. (M)CURRENT ASSETS (M)TANGIBLE ASSETS (M)LONG-T. INVEST. (M)LONG-T. REC. (M)INTANGIBLE ASSETS (M)GOODWILL (M)OTHER NON-CURRENT ASSETS (M)NON-CURRENT ASSETS (M)TOTAL ASSETS (M)LIABILITIESCOMMON STOCK (M)ADDITIONAL PAID-IN CAPITAL (M)RETAINED EARNINGS (M)OTHER EQUITY (M)UNREAL. GAINS/LOSSES (M)EQUITY (M)LIABILITIES (M)PROVISIONS (M)OTHER SHORT-TERM LIAB. (M)SHORT-TERM DEBTS (M)LONG-TERM DEBT PORTION (M)SHORT-TERM REC. (M)LONG-T. LIAB. (M)DEFERRED TAXES (M)OTHER LIAB. (M)LONG-T. LIABILITIES (M)DEBT (M)TOTAL CAPITAL (M)
1991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
                                                             
0.673.724.5411.567.28.5116.334.854.476.014.985.936.389.689.4610.038.065.032.691.322.590.260.430.97.368.0920.7329.5213.316.5219.16
0.020.270.540.366.752.641.342.261.891.42.541.351.241.410.790.9210.80.720.120.450.400.010.592.096.215.71.570.770.55
000000000.651.681.510.850.38000000000000000000
02.011.61.351.792.352.512.952.351.4410.910.891.110.961.260.851.140.880.310.240.180.230.131.552.692.394.124.863.251.47
1.320.120.110.310.490.680.50.550.460.260.220.370.490.590.80.60.820.60.511.350.230.180.310.921.231.072.742.562.452.31.06
2.016.126.7913.5816.2314.1820.6810.619.8210.7910.259.419.3812.7912.0112.8110.737.574.83.13.511.020.971.9610.7313.9432.0741.922.1912.8422.24
0.070.450.560.61.694.715.645.093.341.050.380.20.210.290.240.170.270.160.070.030.040.070.130.190.240.481.32.923.442.892.09
000000000000000000000000002.51.841.220.830.58
000000001.782.841.330.410000000000000000000
0000000000000000000000000000000
0000000000000000000000000000000
3.280.250.240.170.370.540.70.560.390.40.340.30.280.250.220.210.20.190.190.19000.040.160.140.140.20.170.130.071.01
3.350.70.80.772.065.256.345.655.514.292.050.910.490.540.460.380.470.350.260.220.040.070.170.350.380.6244.934.793.793.68
5.366.827.5914.3518.2919.4327.0216.2615.3315.0812.310.329.8713.3312.4713.1911.27.925.063.323.551.091.142.3111.1114.5636.0746.8326.9816.6325.91
                                                             
6.8136.7241.9850.9451.4154.0371.1279.5284.3889.4293.4293.5993.6493.7393.7493.8893.8993.8993.8993.8993.8993.890.2135.2452.45000.01000
0000000000000000.10.270.470.630.8511.5422.40068.22102.98160.29214.43226.8256.92
-2.85-31.06-35.03-37.59-35.59-37.13-51.53-68.14-74.69-82.1-86-86.27-85.75-86.58-87.85-86.53-88.9-90.84-92.46-92.97-98.73-107.11-29.9-36.09-48.51-68.62-105.58-155.39-197.91-219.83-241.85
0-0.29-0.29-0.29-0.31-0.43-0.57-0.72-0.8-1.1-1.11-0.6-0.33-0.32-0.34-0.32-0.31-0.34-0.33-0.34-0.25-0.27000000000
0000000000000000000000000000000
3.965.376.6613.0615.5116.4719.0210.668.896.226.316.727.566.835.557.134.953.181.731.43-4.09-11.95-7.29-0.853.94-0.4-2.64.9116.526.9715.07
0.10.510.210.330.550.870.920.991.341.280.970.40.30.330.350.460.620.30.340.340.150.380.970.421.433.094.83.991.610.881.48
00.380.70.751.981.723.083.22.0521.31.20.730.731.010.711.090.660.50.320.280.450.520.221.272.194.616.083.932.042.61
0000.070.170.340.070.20.140.530.510.350.561.071.681.782.12.412.081.220.280.32000.02000.690.770.380.45
1.30.500003.821.170.821.981.690.990.380000000004.8800000000
00.020.0200000000000000000001.462.54.451.870000.920
1.41.410.931.152.72.937.895.564.355.794.472.941.972.133.042.953.813.372.921.880.711.157.833.147.177.159.4110.766.314.224.53
00.020.010.010.030.030.120.042.083.081.450.41000000005.338.10007.7628.9530.533.984.945.12
0000000000000000000000000000000
0000.130.06000000.070.250.334.373.883.092.441.360.3901.63.80.62000.050.330.630.170.51.19
00.020.010.140.090.030.120.042.083.081.520.660.334.373.883.092.441.360.3906.9311.90.62007.8129.2831.164.155.446.31
1.41.430.941.292.792.968.015.66.438.875.993.62.36.56.926.046.254.733.311.887.6413.058.453.147.1714.9638.6941.9210.469.6610.85
5.366.87.614.3518.319.4327.0316.2615.3215.0912.310.329.8613.3312.4713.1711.27.915.043.313.551.11.162.2911.1114.5636.0946.8326.9816.6325.91
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Viveve Medical provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Viveve Medical's financial health and stability.

Assets

Viveve Medical's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Viveve Medical must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Viveve Medical after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Viveve Medical's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M)DEPRECIATION (M)DEFERRED TAXES (M)CHANGES IN WORKING CAPITAL (M)NON-CASH ITEM (M)PAID INTEREST (M)PAID TAXES (M)NET CASH FLOW FROM OPERATING ACTIVITIES (M)CAPITAL EXPENDITURES (M)CASH FLOW FROM INVESTING ACTIVITIES (M)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M)INTEREST INCOME AND EXPENSES (M)NET DEBT CHANGE (M)NET CHANGE IN EQUITY (M)CASH FLOW FROM FINANCING ACTIVITIES (M)CASH FLOW FROM OTHER FINANCING ACTIVITIES ()TOTAL DIVIDENDS PAID (M)NET CHANGE IN CASH FLOW (M)FREE CASH FLOW (M)SHARE-BASED COMPENSATION (M)
19901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021
0-2-28-3-22-1-14-16-6-7-3000-11-2-1-10-5-8-4-6-12-20-36-49-42-21-22
00000012323000000000000000000111
00000000000000000000000000000000
00000-532001-10041-10-1-1-1000000-10-204
0025000000000000000000340001251253
00000000000000000000000000022200
00000000000000000000000000000000
0-1-3-3-1-33-10-14-3-1-400300-1-2-2-1-3-3-3-5-12-18-34-43-31-15-12
00000-1-4-2-2-1-100000000000000000-2-100
0-300-80-3-1010-1-10000-623000000000-3-2-100
0-300-711-712000000-624000100000-20000
00000000000000000000000000000000
01-10000180000000000000003225190010
06648022535400000000030041613315416826
075480220535300000000030361819505416925
--------------------------------
00000000000000000000000000000000
01100-3201010003-732-3-2-11-20060128-16-612
-0.09-1.75-3.46-3.86-1.93-4.75-1.14-12.69-16.83-4.38-3.27-4.820.940.523.18-0.190.39-2-3-2.37-1.35-3.41-3.24-3.76-6.11-12.31-18.35-35.76-45.23-32.33-16.01-13.33
00000000000000000000000000000000

Viveve Medical stock margins

The Viveve Medical margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Viveve Medical. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Viveve Medical.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Viveve Medical's sales revenue. A higher gross margin percentage indicates that the Viveve Medical retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Viveve Medical's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Viveve Medical's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Viveve Medical's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Viveve Medical. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Viveve Medical's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Viveve Medical Margin History

Viveve Medical Gross marginViveve Medical Profit marginViveve Medical EBIT marginViveve Medical Profit margin
2026e9.65 %-46.2 %-43.99 %
2025e9.65 %-51.63 %-41.24 %
2024e9.65 %-64.14 %-47.5 %
2023e9.65 %-180.7 %-153.96 %
2022e9.65 %-297.81 %-396.74 %
20219.65 %-335.4 %-415.78 %
20205.47 %-337.59 %-475.55 %
201915.53 %-455.56 %-653.12 %
201839.52 %-242.82 %-269.87 %
201748.66 %-220.6 %-241.73 %
201635.43 %-261.9 %-281.65 %
201531.72 %-826.9 %-857.24 %
201444.44 %-6,288.89 %-6,866.67 %
2013-20 %-2,620 %-2,880 %
201250 %-382.41 %-776.85 %
201137.31 %-508.96 %-859.7 %
2010-11.86 %-544.07 %-86.44 %
200955.41 %-34.61 %-34.61 %
200858.72 %-39.59 %-36.4 %
200756.17 %-46.83 %-39.5 %
200661.68 %-7.27 %18.46 %
200559.82 %-19.9 %-16.62 %
200459.45 %-12.68 %-10.96 %
200359.9 %8.52 %6.24 %
200253.73 %2.6 %3.51 %

Viveve Medical Stock Sales Revenue, EBIT, Earnings per Share

The Viveve Medical earnings per share therefore indicates how much revenue Viveve Medical has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Viveve Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Viveve Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Viveve Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Viveve Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Viveve Medical Revenue, EBIT and net profit per share

DateViveve Medical Sales per ShareViveve Medical EBIT per shareViveve Medical Earnings per Share
2026e4.22 undefined0 undefined-1.86 undefined
2025e3.25 undefined0 undefined-1.34 undefined
2024e2.08 undefined0 undefined-0.99 undefined
2023e1.06 undefined0 undefined-1.63 undefined
2022e0.66 undefined0 undefined-2.6 undefined
20210.64 undefined-2.14 undefined-2.65 undefined
20203.49 undefined-11.78 undefined-16.6 undefined
201954.75 undefined-249.42 undefined-357.58 undefined
2018617.33 undefined-1,499 undefined-1,666 undefined
2017764.5 undefined-1,686.5 undefined-1,848 undefined
2016714 undefined-1,870 undefined-2,011 undefined
2015145 undefined-1,199 undefined-1,243 undefined
20140 undefined0 undefined0 undefined
20130 undefined0 undefined0 undefined
20120 undefined0 undefined0 undefined
20110 undefined0 undefined0 undefined
20100 undefined0 undefined0 undefined
20090 undefined0 undefined0 undefined
20080 undefined0 undefined0 undefined
20070 undefined0 undefined0 undefined
20060 undefined0 undefined0 undefined
20050 undefined0 undefined0 undefined
20040 undefined0 undefined0 undefined
20030 undefined0 undefined0 undefined
20020 undefined0 undefined0 undefined

Viveve Medical business model

Viveve Medical Inc. is a company specializing in the development of medical technology. The company is based in Englewood, Colorado, USA, and has been listed on the NASDAQ exchange since 2005. Viveve was founded to meet the needs of women in improving their physical health. The company has developed an innovative technology that allows women to maintain their vaginal health. History of Viveve Medical Inc. Viveve Medical Inc. was founded by an experienced team of physicians and engineers. The company was launched by Dr. William Doyle and a group of experts with extensive experience in the field of medical technology. Dr. Doyle brought his experience in developing technologies to improve skin structure and firmness to the company. The technical expertise of the other team members helped in the development of devices that can improve women's vaginal health. Business model of Viveve Medical Inc. Viveve Medical Inc. is an innovative company that aims to improve women's vaginal health. Viveve's products are based on the patented radiofrequency technology developed by the company. The technology is used in a device called the Viveve System, which is used by medical professionals to help women of different ages in the treatment of pelvic disorders and problems. The company has marketed its products in over 50 countries worldwide. It also collaborates with local distributors and other medical device manufacturers to promote and sell its products on the market. Viveve Medical Inc. offers innovative technologies such as the Viveve System, which allow women to improve their vaginal health and enhance their well-being. The company has various divisions, including medical technology, pharmacy, and medical services. Each division has a different mission and offers different products and services. Products of Viveve Medical Inc. Viveve Medical Inc. has launched several products that aim to improve women's vaginal health. The company's main product is the Viveve System, a device used in the treatment of pelvic disorders and problems. The device utilizes Viveve's patented radiofrequency technology to increase collagen production in tissue. This allows the Viveve System to combat vaginal laxity and incontinence. The Viveve System should always be used by trained medical professionals. In addition to the Viveve System, the company offers other products to improve women's physical health. This includes hormonal therapies that help with hormonal system disorders and alleviate vaginal dryness and pain, as well as surgical interventions for the treatment of irregularities in the female reproductive system. In the pharmaceutical division, the company has effective medications such as kisspeptin in the developmental stage, prescribed for increasing libido in women. Conclusion Overall, Viveve Medical Inc. is a company dedicated to improving women's vaginal health. The company has the innovative technology of the Viveve System and also offers a variety of products and services to enhance women's well-being. Viveve Medical Inc. is a key player in the field of medical technology, providing solutions for a variety of issues. Viveve Medical is one of the most popular companies on Eulerpool.com.

Viveve Medical SWOT Analysis

Strengths

Viveve Medical Inc possesses several strengths that contribute to its competitive advantage in the market. Firstly, the company offers a unique and innovative medical technology known as the Viveve System that addresses various conditions affecting women's health. This proprietary system sets Viveve apart from its competitors and allows it to target a niche market segment. Additionally, the company has an experienced research and development team, enabling it to continually enhance its product offerings and stay ahead in the rapidly evolving healthcare industry.

Furthermore, Viveve Medical Inc has established strong partnerships and collaboration with healthcare providers, securing extensive distribution networks and expanding its market reach. These partnerships not only help in promoting the company's products but also provide valuable insights and feedback for product improvement.

Weaknesses

Despite its strengths, Viveve Medical Inc also faces certain weaknesses that need to be addressed. Firstly, as a relatively small company, it may lack the financial resources and brand recognition compared to larger competitors. This could potentially limit its marketing efforts and hinder market penetration.

Moreover, Viveve's product portfolio is currently focused on women's health, which may restrict its target market to a niche segment. Diversification into other healthcare areas could be considered to mitigate this weakness and increase revenue streams.

Opportunities

The evolving healthcare industry presents several opportunities for Viveve Medical Inc. One such opportunity lies in the growing demand for innovative medical technologies and treatments for women's health issues. With its Viveve System, the company is well-positioned to capitalize on this trend and gain a significant market share.

Furthermore, partnerships and collaborations with major pharmaceutical companies or healthcare institutions can open doors to broader distribution channels and increased market exposure. The company could also explore expanding its product offerings to cater to a wider range of healthcare needs, tapping into additional market segments.

Threats

Viveve Medical Inc faces certain threats that could potentially impact its business operations and market position. The competitive landscape is a significant threat, as larger and more established companies with greater resources may enter the women's health market or develop competing technologies. This could lead to increased competition and potential loss of market share for Viveve.

Additionally, regulatory and compliance requirements in the healthcare industry pose ongoing threats. Changes in regulations or delays in obtaining necessary approvals may hinder the company's ability to launch and market new products in a timely manner.

Viveve Medical Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Viveve Medical historical P/E ratio, EBIT multiple, and P/S ratio

Viveve Medical shares outstanding

The number of shares was Viveve Medical in 2023 — This indicates how many shares 10.09 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Viveve Medical earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Viveve Medical's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Viveve Medical’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Viveve Medical's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Viveve Medical stock splits

In Viveve Medical's history, there have been no stock splits.
Unfortunately, there are currently no price targets and forecasts available for Viveve Medical.

Viveve Medical latest earnings and earnings surprises

DateEPS EstimateEPS ActualQuarterly report
9/30/2022-0.67 -0.59  (12.36 %)2022 Q3
6/30/2022-0.68 -0.67  (1.96 %)2022 Q2
3/31/2022-0.69 -0.67  (2.69 %)2022 Q1
12/31/2021-0.61 -0.72  (-18.64 %)2021 Q4
9/30/2021-0.63 -0.67  (-6.81 %)2021 Q3
6/30/2021-0.66 -0.62  (6.49 %)2021 Q2
3/31/2021-0.52 -0.8  (-53.79 %)2021 Q1
12/31/2020-2.65 -1.85  (30.11 %)2020 Q4
9/30/2020-5.41 -2.6  (51.91 %)2020 Q3
6/30/2020-6.02 -4.4  (26.89 %)2020 Q2
1
2
3
4
...
5

Viveve Medical shareholders

%
Name
Stocks
Change
Date
0 % Quadrant Private Wealth Management, LLC0-10,0003/31/2023
0 % Osaic Holdings, Inc.0-5,5003/31/2023
0 % Group One Trading, L.P.0-13/31/2023
0 % Morgan Stanley Smith Barney LLC0-23/31/2023
0 % Virtu Americas LLC0-22,4439/30/2022
0 % Tower Research Capital LLC0-2,5143/31/2023
0 % Geode Capital Management, L.L.C.0-51,3553/31/2023
0 % Two Sigma Investments, LP0-14,4323/31/2023
0 % Millennium Management LLC0-16,8899/30/2022
0 % Renaissance Technologies LLC0-32,0003/31/2023
1
2
3

Viveve Medical Executives and Management Board

Mr. Scott Durbin53
Viveve Medical Chief Executive Officer, Director (since 2013)
Compensation 2.68 M
Mr. Jim Robbins58
Viveve Medical Senior Vice President - Finance and Administration
Compensation 701,049
Mr. Steven Basta55
Viveve Medical Independent Chairman of the Board
Compensation 469,443
Ms. Arlene Morris
Viveve Medical Independent Director
Compensation 232,630
Ms. Deborah Jorn64
Viveve Medical Independent Director
Compensation 208,880
1
2

Viveve Medical Supply Chain

NameRelationshipTwo-week correlationOne-month correlationThree-Month CorrelationSix-Month CorrelationOne Year CorrelationTwo-Year Correlation
Excelsior Medical Stock
Excelsior Medical
SupplierCustomer0,460,620,18-0,51-0,62-0,35
Merck & Co Stock
Merck & Co
SupplierCustomer-0,53-0,48-0,33-0,59-0,42-0,31
1

Most common questions regarding Viveve Medical

What values and corporate philosophy does Viveve Medical represent?

Viveve Medical Inc is a leading medical technology company focused on women's health. The company's core values include innovation, quality, and patient-centricity. Through their innovative solutions, Viveve aims to improve the lives of women by addressing various health conditions. Their corporate philosophy emphasizes a commitment to scientific rigor, evidence-based practices, and delivering safe and effective treatments. Viveve Medical Inc prioritizes providing exceptional patient care and improving quality of life through their advanced medical devices. With a strong focus on research and development, the company continues to develop and market innovative solutions to meet the evolving needs of women worldwide.

In which countries and regions is Viveve Medical primarily present?

Viveve Medical Inc is primarily present in various countries and regions across the globe. The company has a global presence with a focus on North America, Europe, Asia, and the Middle East. Viveve Medical Inc has established its operations and market reach in countries like the United States, Canada, Germany, France, the United Kingdom, China, Japan, Australia, and the United Arab Emirates. With its strategic expansion plans, Viveve Medical Inc continues to strengthen its market presence and deliver innovative medical solutions in these key regions, providing its products and services to healthcare professionals and patients worldwide.

What significant milestones has the company Viveve Medical achieved?

Viveve Medical Inc, a leading medical technology company, has achieved several significant milestones. As of now, the company has successfully developed and commercialized its innovative Viveve System. This non-invasive treatment option offers effective vaginal tissue restoration and rejuvenation, addressing conditions such as vaginal laxity. Viveve Medical has also expanded its global presence by obtaining regulatory approvals and launching its products in various countries, including the United States, Canada, and Europe. Moreover, Viveve Medical Inc has made advancements in clinical research, demonstrating the safety and efficacy of its products in multiple studies. These achievements have strengthened Viveve Medical's position as a trusted provider of innovative women's health solutions.

What is the history and background of the company Viveve Medical?

Viveve Medical Inc is a renowned medical technology company that specializes in women's health solutions. Founded in 2005, the company has emerged as a pioneering force in offering non-invasive treatments for common feminine health concerns. Viveve Medical is known for its patented Viveve System, which utilizes radiofrequency energy to stimulate collagen production and improve tissue restoration. With a commitment to innovation and clinical research, the company aims to enhance the lives of women worldwide. Viveve Medical Inc continues to evolve and expand its portfolio of advanced solutions for a range of medical conditions related to women's health.

Who are the main competitors of Viveve Medical in the market?

The main competitors of Viveve Medical Inc in the market are BTL Industries, InMode Ltd, and Lumenis Ltd. These companies also operate in the medical aesthetics industry and offer products and services similar to Viveve Medical Inc. BTL Industries specializes in non-invasive body shaping and tightening, while InMode Ltd is known for its innovative radiofrequency-based aesthetic solutions. Lumenis Ltd is a global leader in energy-based medical solutions, including those for women's health issues. The competition among these companies drives innovation and enhances options for customers seeking medical treatment in the aesthetic field.

In which industries is Viveve Medical primarily active?

Viveve Medical Inc primarily operates in the healthcare industry.

What is the business model of Viveve Medical?

Viveve Medical Inc is a medical technology company specializing in women's health. Its business model revolves around developing and commercializing innovative solutions to address various medical conditions affecting women. The company's flagship product, Viveve System, utilizes cryogen-cooled monopolar radiofrequency (CMRF) technology to provide non-invasive treatment for vaginal laxity. This cutting-edge technology stimulates collagen production and tightens the vaginal tissue, ultimately enhancing sexual function and improving overall quality of life for women. Viveve Medical Inc aims to improve women's health outcomes by offering clinically proven and safe solutions for conditions that often go untreated or undiagnosed.

What is the P/E ratio of Viveve Medical 2024?

The Viveve Medical P/E ratio is -0.

What is the P/S ratio of Viveve Medical 2024?

The Viveve Medical P/S ratio is 0.

What is the AlleAktien quality score of Viveve Medical?

The AlleAktien quality score for Viveve Medical is 4/10.

What is the revenue of Viveve Medical 2024?

The expected Viveve Medical revenue is 22.33 M USD.

How high is the profit of Viveve Medical 2024?

The expected Viveve Medical profit is -10.61 M USD.

What is the business model of Viveve Medical

Viveve Medical Inc. is an innovative and advanced company in the field of medical technology, specializing in the development and marketing of devices and products for the treatment of sexual dysfunction, incontinence, and other women-specific health problems. The main product of Viveve Medical Inc. is the Viveve System, a non-invasive method for strengthening and tightening vaginal tissue through collagen stimulation. The Viveve System uses targeted radiofrequency energy to stimulate collagen production and firm the vaginal tissue, resulting in improved sexual function, better bladder control, and reduced risk of vaginal dryness. Additionally, Viveve Medical Inc. offers a range of products to improve female health and well-being, including feminine hygiene products, treatments for menstrual discomfort and post-menopausal symptoms, and contraceptive products. The business activities of Viveve Medical Inc. are conducted in three main segments: Cardiovascular/International Markets, US Business, and OEM (Original Equipment Manufacturer). In the Cardiovascular/International Markets segment, the company's activities are focused on marketing its products and services in international markets, as well as developing product and service offerings for cardiovascular diseases. The US Business segment focuses on marketing the Viveve System in the American market and developing new products for marketing in the US. In this segment, Viveve offers a range of services to ensure product quality, reliability, and safety. The OEM segment deals with the development and provision of solutions for custom product needs and requirements of international partners and customers. The company offers customized products and services to meet the needs of its customers. Overall, Viveve Medical Inc.'s business model is focused on providing innovative and high-quality products and services in the field of female health and well-being. By diversifying its activities in various business areas and focusing on the development and marketing of new products and services, Viveve Medical Inc. is well positioned to further expand its leading position in the medical technology industry.

What is the Viveve Medical dividend?

Viveve Medical pays a dividend of 0 USD distributed over payouts per year.

How often does Viveve Medical pay dividends?

The dividend cannot currently be calculated for Viveve Medical or the company does not pay out a dividend.

What is the Viveve Medical ISIN?

The ISIN of Viveve Medical is US92852W5013.

What is the Viveve Medical WKN?

The WKN of Viveve Medical is A2QJQB.

What is the Viveve Medical ticker?

The ticker of Viveve Medical is VIVE.

How much dividend does Viveve Medical pay?

Over the past 12 months, Viveve Medical paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Viveve Medical is expected to pay a dividend of 0 USD.

What is the dividend yield of Viveve Medical?

The current dividend yield of Viveve Medical is .

When does Viveve Medical pay dividends?

Viveve Medical pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Viveve Medical?

Viveve Medical paid dividends every year for the past 0 years.

What is the dividend of Viveve Medical?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Viveve Medical located?

Viveve Medical is assigned to the 'Health' sector.

Wann musste ich die Aktien von Viveve Medical kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Viveve Medical from 10/5/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/5/2024.

When did Viveve Medical pay the last dividend?

The last dividend was paid out on 10/5/2024.

What was the dividend of Viveve Medical in the year 2023?

In the year 2023, Viveve Medical distributed 0 USD as dividends.

In which currency does Viveve Medical pay out the dividend?

The dividends of Viveve Medical are distributed in USD.

All fundamentals about Viveve Medical

Our stock analysis for Viveve Medical Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Viveve Medical Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.